<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00946868</url>
  </required_header>
  <id_info>
    <org_study_id>0143/09</org_study_id>
    <nct_id>NCT00946868</nct_id>
  </id_info>
  <brief_title>Prevalence of Metabolic Syndrome in Patients With Intermittent Claudication</brief_title>
  <official_title>Prevalence of Metabolic Syndrome in Patients With Intermittent Claudication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Metabolic syndrome, a group of cardiovascular risk factors related to insulin resistance, is&#xD;
      a major determinant of cardiovascular mortality.&#xD;
&#xD;
      Intermittent claudication is a symptom of an early stage of atherosclerosis.&#xD;
&#xD;
      The aim of this study is to determine the prevalence of the metabolic syndrome in patients&#xD;
      with intermittent claudication and its correlation with age, gender, localization of arterial&#xD;
      obstruction and association with coronary artery disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies correlating metabolic syndrome and several illnesses are being published, especially&#xD;
      affections associated with atherosclerosis, like coronary artery disease, cerebrovascular&#xD;
      disease and peripheral arterial disease.&#xD;
&#xD;
      The term peripheral arterial disease, however, refers to several stages of the development of&#xD;
      atherosclerosis in the extremities, comprising since asymptomatic patients as far as&#xD;
      individuals with critical ischemia.&#xD;
&#xD;
      Intermittent claudication is a symptom of an early stage of atherosclerosis, when medical&#xD;
      interventions may still prevent the progression of the disease. Despite the importance of a&#xD;
      precocious diagnosis of metabolic syndrome to initiate adequate treatment, its prevalence&#xD;
      among these patients is not well determined in the literature.&#xD;
&#xD;
      This is the biggest casuistic in the literature as far as we know.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of metabolic syndrome in patients with intermittent claudication</measure>
    <time_frame>After laboratory exams results.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of metabolic syndrome with age, sex, localization of the arterial obstruction and the association with symptomatic coronary artery disease.</measure>
    <time_frame>At the end of data collection</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">170</enrollment>
  <condition>Intermittent Claudication</condition>
  <condition>Metabolic Syndrome X</condition>
  <arm_group>
    <arm_group_label>Intermittent claudication patients</arm_group_label>
    <description>Patients with intermittent claudication with metabolic syndrome and patients with intermittent claudication without metabolic syndrome.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients of the Vascular and Endovascular Department (Intermittent Claudicantion&#xD;
        Group)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients with complaints compatible with intermittent claudication of the lower&#xD;
             limbs, absence or weakness of arterial pulses on the limb or limbs that are limiting&#xD;
             deambulation, ankle-brachial index simila or lower than 0.9&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with critical limb ischaemia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nelson Wolosker, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pedro P Leao, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>05403 000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Ambrosetti M, Salerno M, Laporta A, Pedretti RF. Metabolic syndrome in patients with intermittent claudication referred to vascular rehabilitation. Int Angiol. 2006 Mar;25(1):14-7.</citation>
    <PMID>16520719</PMID>
  </results_reference>
  <results_reference>
    <citation>Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care. 2004 Oct;27(10):2444-9.</citation>
    <PMID>15451914</PMID>
  </results_reference>
  <results_reference>
    <citation>Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003 Mar;26(3):575-81.</citation>
    <PMID>12610004</PMID>
  </results_reference>
  <results_reference>
    <citation>Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002 Jan 16;287(3):356-9.</citation>
    <PMID>11790215</PMID>
  </results_reference>
  <results_reference>
    <citation>Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486-97.</citation>
    <PMID>11368702</PMID>
  </results_reference>
  <results_reference>
    <citation>National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec 17;106(25):3143-421.</citation>
    <PMID>12485966</PMID>
  </results_reference>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>July 23, 2009</study_first_submitted>
  <study_first_submitted_qc>July 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2009</study_first_posted>
  <last_update_submitted>July 23, 2009</last_update_submitted>
  <last_update_submitted_qc>July 23, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2009</last_update_posted>
  <responsible_party>
    <name_title>Nelson Wolosker, PhD</name_title>
    <organization>University of Sao Paulo</organization>
  </responsible_party>
  <keyword>intermittent claudication</keyword>
  <keyword>metabolic syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intermittent Claudication</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

